MT VET COBRE PROJECT 2: METAL UPTAKE AND REGULATION IN STREPTOCOCCUS PYOGENES
MT VET COBRE 项目 2:化脓性链球菌的金属吸收和调节
基本信息
- 批准号:7721026
- 负责人:
- 金额:$ 17.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:BacteriaBindingCellsComputer Retrieval of Information on Scientific Projects DatabaseDiseaseErythrocytesFundingGrantGrowthHemeHemoglobinHumanInfectious Skin DiseasesInstitutionIronMammalsMembrane ProteinsMetalsModelingPathway interactionsPharyngeal structureProcessProteinsRegulationResearchResearch PersonnelResourcesRoleSourceStaphylococcus aureusStreptococcus pyogenesToxic Shock SyndromeUnited States National Institutes of Healthhuman tissuenovel therapeuticspathogenuptake
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The bacteria known as Streptococcus pyogenes and Staphylococcus aureus are important human pathogens that cause a variety of diseases, including strep throat, toxic shock syndrome, and/or skin infection. These bacteria require iron for growth. However, free iron is quite scarce in human tissues, and bacteria have developed several approaches for acquiring the iron needed for their growth. The majority of iron in mammals is heme, which is present in some proteins. For example, one of the most common heme-containing proteins in humans is hemoglobin from red blood cells. To obtain iron, bacteria have developed approaches for acquiring heme from host proteins and internalizing it, which is degraded to provide bacterial cells with the needed iron. The heme acquisition machineries in Streptococcus pyogenes and Staphylococcus aureus consist of surface proteins and a transmembrane transporter. However, the specific pathway and mechanism of the heme acquisition process are not well understood. The roles of the surface proteins of Streptococcus pyogenes and Staphylococcus aureus in the heme acquisition process by these bacteria have been studied. The surface protein Shr of Streptococcus pyogenes binds heme, and the other surface protein Shp relays heme from Shr to the transmembrane transporter. It also has been demonstrated that the surface protein IsdA of Staphylococcus aureus directly and rapidly transfers its heme to the other surface protein IsdC. These studies suggest that these surface proteins relay heme from host proteins to the transporter for subsequent internalization. These results greatly enhance our understanding of the mechanisms of heme acquisition in Streptococcus pyogenes and Staphylococcus aureus and may serve as a general model for heme acquisition in many other Gram-positive pathogens. Understanding of how these bacteria utilize heme to survive in humans may provide clues on how to block the heme transport for developing new therapeutics to combat these harmful pathogens.
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
化脓性链球菌和金黄色葡萄球菌是人类重要的病原体,可引起多种疾病,包括链球菌咽喉、中毒性休克综合征和/或皮肤感染。这些细菌需要铁才能生长。然而,人体组织中的游离铁相当稀缺,细菌已经开发出几种方法来获取它们生长所需的铁。哺乳动物体内的铁主要是血红素,它存在于一些蛋白质中。例如,人类中最常见的含有血红素的蛋白质之一是来自红细胞的血红蛋白。为了获得铁,细菌已经开发出从宿主蛋白中获取血红素并将其内化的方法,这些血红素被降解,为细菌细胞提供所需的铁。化脓性链球菌和金黄色葡萄球菌的血红素捕获机制由表面蛋白和跨膜转运蛋白组成。然而,血红素获得过程的具体途径和机制还不是很清楚。研究了化脓性链球菌和金黄色葡萄球菌表面蛋白在这两种细菌获取血红素过程中的作用。化脓性链球菌的表面蛋白Shr与血红素结合,另一种表面蛋白SHP将血红素从Shr传递到跨膜转运体。研究还表明,金黄色葡萄球菌的表面蛋白ISDA可以直接、快速地将其血红素转移到另一种表面蛋白ISDC上。这些研究表明,这些表面蛋白将血红素从宿主蛋白传递到转运体,以便随后内化。这些结果极大地加深了我们对化脓性链球菌和金黄色葡萄球菌中获得血红素的机制的理解,并可作为许多其他革兰氏阳性病原菌获得血红素的通用模型。了解这些细菌是如何利用血红素在人类体内生存的,可能会为如何阻止血红素的运输提供线索,从而开发新的疗法来对抗这些有害的病原体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BENFANG LEI其他文献
BENFANG LEI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BENFANG LEI', 18)}}的其他基金
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10171774 - 财政年份:2020
- 资助金额:
$ 17.99万 - 项目类别:
A Murine Group A Streptococcus Transmission Model for Male-Biased Acute Infection in the Mucosa of the Upper Respiratory Tract
上呼吸道粘膜男性偏向急性感染的小鼠 A 组链球菌传播模型
- 批准号:
10040605 - 财政年份:2020
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8297945 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8604673 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
9001240 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8788345 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8371028 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Vaccine and therapeutic antibodies against Group A Streptococcus
针对 A 组链球菌的疫苗和治疗抗体
- 批准号:
8495257 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
Evasion of Innate Immunity by Group A Streptococcus
A 组链球菌逃避先天免疫
- 批准号:
8417645 - 财政年份:2012
- 资助金额:
$ 17.99万 - 项目类别:
MT VET COBRE PROJECT 2: HEME UPTAKE PATHWAYS IN GRAM-POSITIVE PATHOGENS
MT VET COBRE 项目 2:革兰氏阳性病原体中的血红素摄取途径
- 批准号:
7960526 - 财政年份:2009
- 资助金额:
$ 17.99万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
- 批准号:
10721983 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Mechanisms of selective binding of small extracellular vesicles to recipient cells as revealed by single-particle tracking
单粒子追踪揭示小细胞外囊泡与受体细胞选择性结合的机制
- 批准号:
23KJ1045 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Comprehensive Maps of U1 snRNP Binding to Nascent RNA in Human Cells
U1 snRNP 与人类细胞中新生 RNA 结合的综合图谱
- 批准号:
10507429 - 财政年份:2022
- 资助金额:
$ 17.99万 - 项目类别:
Analysis of two novel CdGAP binding partners, LIMD1 and Talin, in tension-regulated focal adhesion dynamics in breast cancer cells
乳腺癌细胞张力调节粘着斑动力学中两种新型 CdGAP 结合伴侣 LIMD1 和 Talin 的分析
- 批准号:
485998 - 财政年份:2022
- 资助金额:
$ 17.99万 - 项目类别:
Studentship Programs
Elucidating the binding targets of Staufen1 in human hematopoietic stem cells
阐明 Staufen1 在人类造血干细胞中的结合靶点
- 批准号:
577728-2022 - 财政年份:2022
- 资助金额:
$ 17.99万 - 项目类别:
Canadian Graduate Scholarships Foreign Study Supplements
Development of a SARS-CoV-2 spike protein binding assay using human epithelial cells for COVID-19 therapy discovery and development
使用人类上皮细胞开发 SARS-CoV-2 刺突蛋白结合测定法,用于发现和开发 COVID-19 疗法
- 批准号:
84361 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Collaborative R&D
Fatty acid binding-proteins and endocannabinoids in the retina; roles in glial reactivity and reprogramming of Muller glia into progenitor cells
视网膜中的脂肪酸结合蛋白和内源性大麻素;
- 批准号:
10094598 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Inducing transcriptional reprogramming of leukemic B-cells by facilitating transcription factors binding to nascent decondensed chromatin
通过促进转录因子与新生脱浓缩染色质结合来诱导白血病 B 细胞的转录重编程
- 批准号:
10408669 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
The use of genetic code expansion to understand and enhance the activity of p19, an RNA binding protein, towards applications in human cells for the modulation of small regulatory RNA molecules
利用遗传密码扩展来理解和增强 p19(一种 RNA 结合蛋白)的活性,以在人类细胞中用于调节小调节 RNA 分子
- 批准号:
535311-2019 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Postgraduate Scholarships - Doctoral
Fatty acid binding-proteins and endocannabinoids in the retina; roles in glial reactivity and reprogramming of Muller glia into progenitor cells
视网膜中的脂肪酸结合蛋白和内源性大麻素;
- 批准号:
10320023 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:














{{item.name}}会员




